Free Trial
→ I was wrong about Trump (From Porter & Company) (Ad) Free TELO Stock Alerts

Telomir Pharmaceuticals (TELO) Institutional Ownership

Telomir Pharmaceuticals logo
$1.16 +0.03 (+2.21%)
As of 01:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)

Number of
Institutional Buyers
(last 12 months)
20
Total
Institutional Inflows
(last 12 months)
$4.13M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$117.88K
Get TELO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TELO Institutional Buying and Selling by Quarter

Telomir Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108%
5/16/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108%
5/13/2025HighTower Advisors LLC43,000$139K0.0%N/A0.144%
5/12/2025Nuveen LLC24,990$81K0.0%N/A0.084%
4/29/2025Bank of New York Mellon Corp91,353$295K0.0%+26.4%0.307%
2/17/2025Nuveen Asset Management LLC24,990$103K0.0%N/A0.084%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036%
2/17/2025Gotham Asset Management LLC6,770$28K0.0%N/A0.023%
2/17/2025Bank of America Corp DE14,713$61K0.0%+283.9%0.049%
2/14/2025Northern Trust Corp151,628$625K0.0%+211.5%0.510%
2/14/2025Transce3nd LLC28,803$119K0.0%N/A0.097%
2/13/2025Barclays PLC29,959$123K0.0%+326.9%0.101%
2/13/2025Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034%
2/12/2025Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390%
2/12/2025JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139%
2/11/2025Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032%
2/11/2025Virtu Financial LLC14,959$62K0.0%N/A0.050%
2/6/2025Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157%
2/4/2025Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244%
1/30/2025Rhumbline Advisers8,600$35K0.0%+105.9%0.029%
11/19/2024Barclays PLC7,018$45K0.0%+325.1%0.024%
11/16/2024Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806%
11/15/2024Barclays PLC7,018$45K0.0%+325.1%0.024%
11/15/2024State Street Corp36,094$232K0.0%+99.1%0.122%
10/21/2024Suncoast Equity Management51,194$329K0.0%+109.9%0.173%
8/15/2024Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049%
7/26/2024Bank of New York Mellon Corp50,165$241K0.0%N/A0.169%
5/2/2024Suncoast Equity Management24,391$126K0.0%N/A0.082%
(Data available from 1/1/2016 forward)

TELO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TELO shares?

During the previous two years, 21 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($295K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on Telomir Pharmaceuticals' institutional investors.

Which institutional investors have been buying Telomir Pharmaceuticals' stock?

Of the 20 institutional investors that purchased Telomir Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($90.15K), Suncoast Equity Management ($51.19K), HighTower Advisors LLC ($43K), JPMorgan Chase & Co. ($37.98K), and Charles Schwab Investment Management Inc. ($35.56K).

How much institutional buying is happening at Telomir Pharmaceuticals?

Institutional investors have bought a total of 884,336 shares in the last 24 months. This purchase volume represents approximately $4.13M in transactions.

Which of Telomir Pharmaceuticals' major shareholders have been selling company stock?

The following institutional investors have sold Telomir Pharmaceuticals stock in the last 24 months: Goldman Sachs Group Inc. ($36.50K).

How much institutional selling is happening at Telomir Pharmaceuticals?

Institutional investors have sold a total of 36,496 shares in the last 24 months. This volume of shares sold represents approximately $117.88K in transactions.


Related Companies

This page (NASDAQ:TELO) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway
Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!
Interactive Offers | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...
Timothy Sykes | Sponsored
This Social Security Shift Could Boost Benefits by 400%
If you currently collect Social Security—or plan to in the future—this may be one of the most important update...
InvestorPlace | Sponsored
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...
Golden Portfolio | Sponsored